MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway

Aging

Volumn 8, Issue 10, 2016, Pages 2509-2524

  Sun, Cheng Cao ^a   Li, Shu Jun ^a,b   Yuan, Zhan Peng ^a   Li, De Jia ^a  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Hospital for Occupational Disease Prevention and Treatment   (China)

Author keywords

Microrna 346 (miR 346); Non small cell lung cancer (NSCLC); Oncogenesis; XPC

Indexed keywords

CADHERIN; DNA BINDING PROTEIN; MICRORNA; MIRN346 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; SNAI1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SNAIL; XPC PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL; APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; DNA DAMAGE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; NON SMALL CELL LUNG CANCER; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; CADHERINS; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; DNA-BINDING PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICRORNAS; NEOPLASM METASTASIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SNAIL FAMILY TRANSCRIPTION FACTORS;

EID: 84995546050     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.101080     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90. doi: 10.3322/caac.20107
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87-108. doi: 10.3322/caac.21262
3. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66:115-32. doi: 10.3322/caac.21338
4. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006; 24:4539-44. doi: 10.1200/JCO.2005.04.4859
5. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet. 2009; 5:e1000459. doi: 10.1371/journal.pgen.1000459
6. Liu X, Zheng Q, Vrettos N, Maragkakis M, Alexiou P, Gregory BD, Mourelatos Z. A MicroRNA precursor surveillance system in quality control of MicroRNA synthesis. Mol Cell. 2014; 55:868-79. doi: 10.1016/j.molcel.2014.07.017
7. Belgardt BF, Ahmed K, Spranger M, Latreille M, Denzler R, Kondratiuk N, von Meyenn F, Villena FN, Herrmanns K, Bosco D, Kerr-Conte J, Pattou F, Rülicke T, Stoffel M. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nat Med. 2015; 21:619-27. doi: 10.1038/nm.3862
8. Li Y, Kuscu C, Banach A, Zhang Q, Pulkoski-Gross A, Kim D, Liu J, Roth E, Li E, Shroyer KR, Denoya PI, Zhu X, Chen L, Cao J. miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14. Cancer Res. 2015; 75:2674-85. doi: 10.1158/0008-5472.CAN-14-2875
9. Dinami R, Ercolani C, Petti E, Piazza S, Ciani Y, Sestito R, Sacconi A, Biagioni F, le Sage C, Agami R, Benetti R, Mottolese M, Schneider C, et al. miR-155 drives telomere fragility in human breast cancer by targeting TRF1. Cancer Res. 2014; 74:4145-56. doi: 10.1158/0008-5472.CAN-13-2038
10. Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter C, Chen X, Vlassov AV, Tang DG. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res. 2014; 74:4183-95. doi: 10.1158/0008-5472.CAN-14-0404
11. Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N, Zhou X, Chen C. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget. 2014; 5:11873-85. doi: 10.18632/oncotarget.2662
12. Wulczyn FG, Smirnova L, Rybak A, Brandt C, Kwidzinski E, Ninnemann O, Strehle M, Seiler A, Schumacher S, Nitsch R. Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J. 2007; 21:415-26. doi: 10.1096/fj.06-6130com
13. Mei Q, Xue G, Li X, Wu Z, Li X, Yan H, Guo M, Sun S, Han W. Methylation-induced loss of miR-484 in microsatellite-unstable colorectal cancer promotes both viability and IL-8 production via CD137L. J Pathol. 2015; 236:165-74. doi: 10.1002/path.4525
14. Díaz-Martín J, Díaz-López A, Moreno-Bueno G, Castilla MA, Rosa-Rosa JM, Cano A, Palacios J. A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition. J Pathol. 2014; 232:319-29. doi: 10.1002/path.4289
15. Hsu CY, Hsieh TH, Tsai CF, Tsai HP, Chen HS, Chang Y, Chuang HY, Lee JN, Hsu YL, Tsai EM. miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. J Pathol. 2014; 232:330-43. doi: 10.1002/path.4295
16. Sun C, Liu Z, Li S, Yang C, Xue R, Xi Y, Wang L, Wang S, He Q, Huang J, Xie S, Jiang W, Li D. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. Oncotarget. 2015; 6:25533-74. doi: 10.18632/oncotarget.4575
17. Sun C, Sang M, Li S, Sun X, Yang C, Xi Y, Wang L, Zhang F, Bi Y, Fu Y, Li D. Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget. 2015; 6:39756-92. doi: 10.18632/oncotarget.5476
18. Huang CF, Sun CC, Zhao F, Zhang YD, Li DJ. miR-33a levels in hepatic and serum after chronic HBVinduced fibrosis. J Gastroenterol. 2015; 50:480-90. doi: 10.1007/s00535-014-0986-3
19. Chen J, Tian J, Tang X, Rui K, Ma J, Mao C, Liu Y, Lu L, Xu H, Wang S. MiR-346 regulates CD4+CXCR5+ T cells in the pathogenesis of Graves' disease. Endocrine. 2015; 49:752-60. doi: 10.1007/s12020-015-0546-5
20. Semaan N, Frenzel L, Alsaleh G, Suffert G, Gottenberg JE, Sibilia J, Pfeffer S, Wachsmann D. miR-346 controls release of TNF-a protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization. PLoS One. 2011; 6:e19827. doi: 10.1371/journal.pone.0019827
21. Guo J, Lv J, Liu M, Tang H. miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy. J Biol Chem. 2015; 290:30342-50.
22. Song G, Wang R, Guo J, Liu X, Wang F, Qi Y, Wan H, Liu M, Li X, Tang H. miR-346 and miR-138 competitively regulate hTERT in GRSF1-and AGO2-dependent manners, respectively. Sci Rep. 2015; 5:15793. doi: 10.1038/srep15793
23. Chen B, Pan W, Lin X, Hu Z, Jin Y, Chen H, Ma G, Qiu Y, Chang L, Hua C, Zou Y, Gao Y, Ying H, Lv D. MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma. Tumour Biol. 2016; 37:2765-71. doi: 10.1007/s13277-015-4046-2
24. Wang Q, Cai J, Cai XH, Chen L. miR-346 regulates osteogenic differentiation of human bone marrowderived mesenchymal stem cells by targeting the Wnt/β-catenin pathway. PLoS One. 2013; 8:e72266. doi: 10.1371/journal.pone.0072266
25. Semaan N, Frenzel L, Alsaleh G, Suffert G, Gottenberg JE, Sibilia J, Pfeffer S, Wachsmann D. miR-346 controls release of TNF-a protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization. PLoS One. 2011; 6:e19827. doi: 10.1371/journal.pone.0019827
26. Legerski R, Peterson C. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature. 1992; 360:610. doi: 10.1038/360610b0
27. Yang PW, Hsieh CY, Kuo FT, Huang PM, Hsu HH, Kuo SW, Chen JS, Lee JM. The survival impact of XPA and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2013; 20:562-71. doi: 10.1245/s10434-012-2622-x
28. Hollander MC, Philburn RT, Patterson AD, Velasco-Miguel S, Friedberg EC, Linnoila RI, Fornace AJ Jr. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci USA. 2005; 102:13200-05. doi: 10.1073/pnas.0503133102
29. Yang J, Xu Z, Li J, Zhang R, Zhang G, Ji H, Song B, Chen Z. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome. J Urol. 2010; 184:336-43. doi: 10.1016/j.juro.2010.03.044
30. Cui T, Srivastava AK, Han C, Yang L, Zhao R, Zou N, Qu M, Duan W, Zhang X, Wang QE. XPC inhibits NSCLC cell proliferation and migration by enhancing ECadherin expression. Oncotarget. 2015; 6:10060-72. doi: 10.18632/oncotarget.3542
31. Sun C, Yang C, Xue R, Li S, Zhang T, Pan L, Ma X, Wang L, Li D. Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2. J Appl Physiol (1985). 2015; 118:224-37. doi: 10.1152/japplphysiol.00744.2014
32. Sun CC, Li SJ, Yang CL, Xue RL, Xi YY, Wang L, Zhao QL, Li DJ. Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-?B Signaling Pathway. J Biol Chem. 2015; 290:17784-95. doi: 10.1074/jbc.M115.655019
33. Sun C, Li S, Li D. Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling. J Appl Physiol (1985). 2016; 120:377-90. doi: 10.1152/japplphysiol.00721.2015
34. Wu YH, Tsai Chang JH, Cheng YW, Wu TC, Chen CY, Lee H. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Oncogene. 2007; 26:4761-73. doi: 10.1038/sj.onc.1210284
35. Lau MT, Leung PC. The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells. Cancer Lett. 2012; 326:191-98. doi: 10.1016/j.canlet.2012.08.016
36. Hsu YL, Hou MF, Kuo PL, Huang YF, Tsai EM. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013; 32:4436-47. doi: 10.1038/onc.2012.444
37. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-33. doi: 10.1016/j.cell.2009.01.002
38. Hollander MC, Philburn RT, Patterson AD, Velasco-Miguel S, Friedberg EC, Linnoila RI, Fornace AJ Jr. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci USA. 2005; 102:13200-05. doi: 10.1073/pnas.0503133102
39. Han W, Soltani K, Ming M, He YY. Deregulation of XPC and CypA by cyclosporin A: an immunosuppressionindependent mechanism of skin carcinogenesis. Cancer Prev Res (Phila). 2012; 5:1155-62. doi: 10.1158/1940-6207.CAPR-12-0185-T
40. Wu YH, Wu TC, Liao JW, Yeh KT, Chen CY, Lee H. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression. Cancer Res. 2010; 70:10422-32. doi: 10.1158/0008-5472.CAN-10-2615
41. Nollet F, Berx G, van Roy F. The role of the Ecadherin/ catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun. 1999; 2:77-85. doi: 10.1006/mcbr.1999.0155
42. Soto E, Yanagisawa M, Marlow LA, Copland JA, Perez EA, Anastasiadis PZ. p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression. J Cell Biol. 2008; 183:737-49. doi: 10.1083/jcb.200805113
43. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene. 2008; 27:6958-69. doi: 10.1038/onc.2008.346
44. Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol. 2004; 24:306-19. doi: 10.1128/MCB.24.1.306-319.2004
45. Singh AB, Sharma A, Smith JJ, Krishnan M, Chen X, Eschrich S, Washington MK, Yeatman TJ, Beauchamp RD, Dhawan P. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Gastroenterology. 2011; 141:2140-53. doi: 10.1053/j.gastro.2011.08.038